Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Outlook Therapeutics, Inc. (OTLK)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
20 Apr 2023
Dagnon Terry
Chief Operations Officer, Officer
Outlook Therapeutics, Inc.
(OTLK)
653,058
-44%
520,000
$1.14
$590,200.00
SELL
20 Jan 2023
Evanson Jeff
Chief Commercial Officer, Officer
Outlook Therapeutics, Inc.
(OTLK)
745,975
-26%
267,000
$1.11
$296,370.00
SELL
17 Jan 2023
Evanson Jeff
Chief Commercial Officer, Officer
Outlook Therapeutics, Inc.
(OTLK)
1,012,975
-13%
164,155
$1.24
$203,725.81
BUY
7 Oct 2022
Sukhtian Faisal Ghiath
Director
Outlook Therapeutics, Inc.
(OTLK)
68,000
+78%
30,000
$1.29
$38,700.00
BUY
6 Oct 2022
Haddadin Yezan Munther
Director
Outlook Therapeutics, Inc.
(OTLK)
63,343
+111%
33,343
$1.29
$42,940.47
BUY
4 Oct 2022
HILZINGER KURT J
Director
Outlook Therapeutics, Inc.
(OTLK)
473,117
+30%
111,203
$1.28
$142,512.14
BUY
29 Sep 2022
HILZINGER KURT J
Director
Outlook Therapeutics, Inc.
(OTLK)
361,914
+32%
88,797
$1.24
$110,500.23
BUY
21 Jun 2022
TRENARY C RUSSELL III
CEO and President, Director, Officer
Outlook Therapeutics, Inc.
(OTLK)
54,925
+56%
19,925
$1.06
$21,120.50
BUY
21 Jun 2022
Dagnon Terry
Chief Operating Officer, Officer
Outlook Therapeutics, Inc.
(OTLK)
1,173,058
+0%
10,000
$1.05
$10,500.00
BUY
1 Mar 2022
HILZINGER KURT J
Director
Outlook Therapeutics, Inc.
(OTLK)
273,117
+11%
27,708
$1.69
$46,826.52
BUY
24 Feb 2022
HILZINGER KURT J
Director
Outlook Therapeutics, Inc.
(OTLK)
245,409
+23%
47,160
$1.48
$69,693.60
BUY
22 Feb 2022
HILZINGER KURT J
Director
Outlook Therapeutics, Inc.
(OTLK)
198,249
+757%
175,132
$1.47
$256,969.94
BUY
6 Dec 2021
TRENARY C RUSSELL III
CEO and President, Director, Officer
Outlook Therapeutics, Inc.
(OTLK)
35,000
+250%
25,000
$1.39
$34,750.00
BUY
6 Dec 2021
Dagnon Terry
Chief Operating Officer, Officer
Outlook Therapeutics, Inc.
(OTLK)
1,163,058
+2%
25,201
$1.38
$34,777.38
BUY
3 Dec 2021
Evanson Jeff
Chief Commercial Officer, Officer
Outlook Therapeutics, Inc.
(OTLK)
1,177,130
+3%
35,200
$1.34
$47,168.00
BUY
3 Dec 2021
Dagnon Terry
Chief Operating Officer, Officer
Outlook Therapeutics, Inc.
(OTLK)
1,137,857
+0%
10,000
$1.42
$14,200.00
BUY
2 Dec 2021
Haddadin Yezan Munther
Director
Outlook Therapeutics, Inc.
(OTLK)
30,000
+50%
10,000
$1.39
$13,900.00
BUY
2 Dec 2021
TRENARY C RUSSELL III
CEO and President, Director, Officer
Outlook Therapeutics, Inc.
(OTLK)
10,000
+100%
10,000
$1.40
$14,000.00
BUY
2 Dec 2021
Sukhtian Faisal Ghiath
Director
Outlook Therapeutics, Inc.
(OTLK)
38,000
+90%
18,000
$1.40
$25,200.00
BUY
29 Nov 2021
Sukhtian Ghiath M.
Director, 10% Owner
Outlook Therapeutics, Inc.
(OTLK)
27,834,256
+135%
16,000,000
$1.25
$20,000,000.00
BUY
20 Apr 2021
KENYON LAWRENCE A
CEO, Pres, CFO, Treas & Secy, Director, Officer
Outlook Therapeutics, Inc.
(OTLK)
18,926
+112%
10,000
$1.83
$18,300.00
BUY
19 Apr 2021
Haddadin Yezan Munther
Director
Outlook Therapeutics, Inc.
(OTLK)
20,000
+100%
10,000
$1.82
$18,200.00
BUY
19 Apr 2021
Sukhtian Faisal Ghiath
Director
Outlook Therapeutics, Inc.
(OTLK)
20,000
+100%
10,000
$1.82
$18,200.00
SELL
23 Feb 2021
Evanson Jeff
Chief Commercial Officer, Officer
Outlook Therapeutics, Inc.
(OTLK)
1,141,930
-0%
8,554
$2.09
$17,860.75
SELL
23 Feb 2021
Dagnon Terry
Chief Operating Officer, Officer
Outlook Therapeutics, Inc.
(OTLK)
1,127,857
-1%
15,900
$2.09
$33,199.20
SELL
12 Feb 2021
Evanson Jeff
Chief Commercial Officer, Officer
Outlook Therapeutics, Inc.
(OTLK)
1,150,484
-4%
56,973
$2.55
$145,281.14
SELL
12 Feb 2021
Dagnon Terry
Chief Operating Officer, Officer
Outlook Therapeutics, Inc.
(OTLK)
1,143,757
-5%
63,700
$2.55
$162,435.00
BUY
3 Feb 2021
Syntone Ventures LLC
10% Owner
Outlook Therapeutics, Inc.
(OTLK)
19,823,044
+17%
3,000,000
$1.00
$3,000,000.00
BUY
2 Feb 2021
Sukhtian Ghiath M.
Director, 10% Owner
Outlook Therapeutics, Inc.
(OTLK)
10,820,630
+339%
8,360,000
$1.00
$8,360,000.00
BUY
22 Sep 2020
Haddadin Yezan Munther
Director
Outlook Therapeutics, Inc.
(OTLK)
10,000
+100%
10,000
$0.72
$7,245.00
BUY
17 Sep 2020
Sukhtian Faisal Ghiath
Director
Outlook Therapeutics, Inc.
(OTLK)
10,000
+100%
10,000
$0.67
$6,731.00
BUY
14 Sep 2020
THURMAN RANDY H
Director
Outlook Therapeutics, Inc.
(OTLK)
11,875
+533%
10,000
$0.62
$6,200.00
BUY
15 Jul 2020
Syntone Ventures LLC
10% Owner
Outlook Therapeutics, Inc.
(OTLK)
16,823,044
+5%
823,045
$1.22
$999,999.70
SELL
18 Sep 2019
KENYON LAWRENCE A
CEO, Pres, CFO, Treas & Secy, Director, Officer
Outlook Therapeutics, Inc.
(OTLK)
80,863
-1%
1,350
$1.70
$2,295.00
BUY
7 Feb 2019
KENYON LAWRENCE A
CEO, Pres, CFO, Treas & Secy, Director, Officer
Outlook Therapeutics, Inc.
(OTLK)
82,213
+3%
3,125
$7.16
$22,380.00
BUY
4 Feb 2019
HILZINGER KURT J
Director
Outlook Therapeutics, Inc.
(OTLK)
184,947
+0%
747.875
$6.40
$4,786.40
BUY
30 Jan 2019
HILZINGER KURT J
Director
Outlook Therapeutics, Inc.
(OTLK)
178,964
+1%
2,423.75
$6.01
$14,559.80
BUY
25 Jan 2019
HILZINGER KURT J
Director
Outlook Therapeutics, Inc.
(OTLK)
159,574
+2%
4,014
$5.65
$22,690.96
BUY
22 Jan 2019
HILZINGER KURT J
Director
Outlook Therapeutics, Inc.
(OTLK)
127,462
+1%
1,626.875
$5.43
$8,827.54
BUY
16 Jan 2019
HILZINGER KURT J
Director
Outlook Therapeutics, Inc.
(OTLK)
114,447
+0%
387.5
$5.50
$2,131.00
BUY
15 Jan 2019
Mohan Pankaj
Director, 10% Owner
Outlook Therapeutics, Inc.
(OTLK)
7,064,553
+0%
1,000
$5.44
$5,440.00
BUY
14 Jan 2019
HILZINGER KURT J
Director
Outlook Therapeutics, Inc.
(OTLK)
111,347
+0%
833.125
$5.65
$4,709.49
BUY
9 Jan 2019
HILZINGER KURT J
Director
Outlook Therapeutics, Inc.
(OTLK)
104,682
+1%
1,105.625
$5.68
$6,275.26
BUY
4 Jan 2019
HILZINGER KURT J
Director
Outlook Therapeutics, Inc.
(OTLK)
95,837
+2%
2,222.625
$4.99
$11,082.03
BUY
31 Dec 2018
HILZINGER KURT J
Director
Outlook Therapeutics, Inc.
(OTLK)
78,056
+2%
2,148.625
$4.72
$10,141.51
BUY
26 Dec 2018
HILZINGER KURT J
Director
Outlook Therapeutics, Inc.
(OTLK)
60,867
+3%
2,294.25
$4.21
$9,651.06
BUY
21 Dec 2018
THURMAN RANDY H
Director
Outlook Therapeutics, Inc.
(OTLK)
15,000
+14%
1,875
$5.47
$10,251.00
BUY
21 Dec 2018
HILZINGER KURT J
Director
Outlook Therapeutics, Inc.
(OTLK)
42,513
+1%
589.125
$5.22
$3,074.58
SELL
18 Sep 2018
KENYON LAWRENCE A
CEO, Pres, CFO, Treas & Secy, Director, Officer
Oncobiologics, Inc.
(ONS)
57,213
-2%
1,262.5
$6.98
$8,807.20
SELL
25 Jun 2018
Bahrt Kenneth
Chief Medical Officer, Officer
Oncobiologics, Inc.
(ONS)
47,120
-2%
962.5
$6.76
$6,507.27
SELL
3 Jan 2018
Mohan Pankaj
President & CEO, Director, Officer, 10% Owner
Oncobiologics, Inc.
(ONS)
7,056,553
-0%
14,334.625
$9.35
$134,067.47
BUY
22 Dec 2017
Bahrt Kenneth
Chief Medical Officer, Officer
Oncobiologics, Inc.
(ONS)
54,820
+6%
3,270.625
$9.04
$29,566.45
SELL
22 Dec 2017
KENYON LAWRENCE A
CFO and Secretary, Officer
Oncobiologics, Inc.
(ONS)
67,313
-4%
3,270.625
$9.04
$29,566.45
SELL
22 Dec 2017
Yamashita Elizabeth A.
VP, Regulatory Affairs, Officer
Oncobiologics, Inc.
(ONS)
64,648
-3%
2,021.25
$9.04
$18,272.10
BUY
22 Dec 2017
MCANDREW STEPHEN J
SVP Bus. Strat. & Dev., Officer
Oncobiologics, Inc.
(ONS)
50,899
+4%
1,963.125
$9.04
$17,746.65
SELL
18 Dec 2017
Mohan Pankaj
President & CEO, Director, Officer, 10% Owner
Oncobiologics, Inc.
(ONS)
7,171,230
-0%
13,016.375
$9.17
$119,325.02
SELL
18 Dec 2017
Yamashita Elizabeth A.
VP, Regulatory Affairs, Officer
Oncobiologics, Inc.
(ONS)
80,818
-1%
957.5
$9.17
$8,777.67
SELL
23 Nov 2016
Griffith Donald J.
Director
Oncobiologics, Inc.
(ONS)
144,926
-0%
0.125
$30.00
$3.75
SELL
9 Nov 2016
Gangloff Scott A.
SVP, Development & Mfrg, Officer
Oncobiologics, Inc.
(ONS)
78,573
-5%
4,671.125
$30.00
$140,133.75
SELL
9 Nov 2016
MCANDREW STEPHEN J
SVP Bus. Strat. & Dev., Officer
Oncobiologics, Inc.
(ONS)
36,604
-6%
2,670.875
$30.00
$80,126.25
Home